Infectious
Respiratory Infection
Respiratory Infection is an infectious condition involving the respiratory system. The term is used broadly here for respiratory tract infections, including illnesses described as community-acquired viral respiratory tract infections and cold- or flu-like illness.
Respiratory Infection is classified as an infectious condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
1 option:1 some evidence
Nasal Irrigation (Neti Pot)practiceSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 3 studies with a clear result found a benefit.
A meta-analysis of randomized trials in infants and children with acute rhinopharyngitis found that saline nasal irrigation benefited nasal symptoms. A retrospective cohort study of 144 people also reported improvements in nasal congestion, runny nose, sleep quality, and appetite.
Open the Nasal Irrigation (Neti Pot) page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedMost likely to help, from the evidence we have
- →PracticesNasal Irrigation (Neti Pot)CertaintyMediumSourceRCT
A meta-analysis of randomized trials in infants and children with acute rhinopharyngitis found that saline nasal irrigation benefited nasal symptoms. A retrospective cohort study of 144 people also reported improvements in nasal congestion, runny nose, sleep quality, and appetite.
Who was studied
- People with a condition
- Allergies
- Respiratory Infection
Open Nasal Irrigation (Neti Pot)Study result
Four RCTs in infants and children with acute rhinopharyngitis; SNI benefit shown for rhinological symptoms.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Respiratory Infection worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Respiratory Infection is an infectious condition involving the respiratory system. The term is used broadly here for respiratory tract infections, including illnesses described as community-acquired viral respiratory tract infections and cold- or flu-like illness. It does not identify one specific infection or cause. Echinacea, Zinc, Garlic, and MCT Oil are discussed as separate studied options, not interchangeable treatments.
Evidence-backed options
The options associated with respiratory infections are not supported equally, and they address different outcomes. Echinacea and Zinc have the clearest clinical support among the options shown, with findings related to preventing illness or shortening symptoms. Garlic and Vitamin C have findings focused on reducing illness severity or its effects, while Quercetin remains a less certain option because more research is needed.
Some findings have limited applicability to people with respiratory infections. MCT Oil and Vitamin K2 are supported by animal research, and the Vitamin A finding concerns Angus-cross steers with subclinical BRD. Rhodiola Rosea was studied in athletes, so that evidence may not apply broadly to other groups. These differences in study population and design matter when interpreting the options.
The findings do not provide a consistent dose, duration of use, or time to onset, so those aspects cannot be compared here. Cod Liver Oil did not reduce the incidence of other acute respiratory infections compared with placebo, illustrating that not every option has shown benefit. For any medical condition, these findings are educational and should be considered with a clinician.